Olympus to Join Government Project to Verify Dissemination of Endoscopic AI Diagnosis in Vietnam
2022年12月6日 - 11:00AM
JCN Newswire
Olympus Corporation (Olympus), a global medtech company
committed to making people's lives healthier, safer and more
fulfilling, today announced their part in a project in cooperation
with the Ministry of Internal Affairs and Communications of Japan
(MIC), entitled, "Survey Study for International Expansion of
Endoscopes Utilizing High-definition Imaging Technology AI
Diagnosis Support System in Vietnam."
This is the third year, after similar projects in Thailand in
fiscal year 2021 and India in fiscal year 2020, that Olympus has
acted as a corporate partner to investigate the effectiveness and
potential dissemination of an AI diagnostic support system. As part
of these projects, Olympus has researched clinical applications in
collaboration with major local medical institutions. Past clinical
use by doctors in India and Thailand, along with consultation with
Japanese physicians, showed the effectiveness and potential for
future use of EndoBRAIN-EYE and other endoscope diagnostic imaging
support software.
From November 2022 to March 2023, Olympus, in collaboration with
CYBERNET SYSTEMS CO., LTD., will conduct research on the
effectiveness and future use of the AI diagnostic support system
EndoBRAIN-EYE at Cho Ray Hospital and 108 Hospital in Vietnam. In
addition, specialist lecturers and physicians from Japan's Showa
University Northern Yokohama Hospital and Shizuoka Cancer Center
will provide expert guidance to doctors at major Vietnamese
hospitals. They will train doctors in techniques for detecting
diseases and differential diagnosis with colonoscopes using
EndoBRAIN-EYE, and they will also instruct on how to train the next
generation of endoscopists.
At the kick-off meeting on November 28, Ho Dang Quy Dung M.D. from
Cho Ray Hospital said, "AI is a new and powerful technology making
endoscpic procedure more efficient and high quality. I do think
that AI will be the big breakthrough of the filed of GI endoscopy
in the upcoming years. I hope we have the opportunity to work with
Japanese experts in the field of AI in endoscopy." Professor
Shin'ei Kudo from Showa University Northern Yokohama Hospital also
commented, "I hope this project will contribute to not only
dissemination of the AI technology but also increased partnership
between Vietnam and Japan, and look forward to amazing results from
this exciting collaboration."
Background of Olympus' Participation
Cancer rates have been on the rise in recent years in Vietnam, and
colorectal cancer in particular has become a significant issue. It
ranks fourth among all cancer cases in men and third among all
cancers in women, as well as ranking second in mortality rate among
all cancers in both men and women. While the demand for endoscopic
screenings, which are essential for the early detection and
treatment of cancer, is expected to increase, there is a shortage
of physicians with the advanced knowledge and skills required for
these examinations. Olympus has joined this project to support the
specialists training doctors in Vietnam, to verify the
effectiveness and dissemination of AI-assisted colonoscopy, and to
contribute to the development of the healthcare environment in
Vietnam.
Purpose of the MIC Project
The MIC aims to realize the sustainable development goals and SDG
pledges to ensure "no one will be left behind." To this end, the
MIC aims to realize a model that contributes to SDG through
digitization and to disseminate and promote an SDG + ICT model
domestically and overseas between both the public and private
sectors. This project aims to contribute to the introduction and
dissemination of Japan's endoscopic AI diagnostic support system to
Vietnam in response to the social issue of increasing cancer
prevalence in Vietnam.
Project Scope:
1) Surveys on the policies in the medical, health, and hygiene
sectors and the introduction of medical information and
communication technology
Information will be collected from major medical institutions and
external research institutions to investigate the state of
dissemination of medical information systems, including endoscopy
systems.
2) Verification through proof-of-concept tests
Research will be conducted on the effectiveness and future use of
the AI diagnosis support system at Cho Ray Hospital and 108
Hospital in Vietnam. Physicians from Showa University Northern
Yokohama Hospital and Shizuoka Cancer Center will train doctors at
major Vietnamese hospitals covering processes from the detection of
disease utilizing a colonoscope with an AI diagnostic support
system to discriminatory diagnosis, as well as provide training in
how to pass on this knowledge to other doctors. Olympus will
provide equipment and training courses.
Company names and product names in this release are trademarks or
registered trademarks of each company.
Products or devices presented include future technology which may
be pending regional regulatory approval and are not available for
sale in all regions.
About Olympus
In its Endoscopic Solutions business, Olympus uses innovative
capabilities in medical technology, therapeutic intervention and
precision manufacturing to help healthcare professionals deliver
diagnostic, therapeutic and minimally invasive procedures to
improve clinical outcomes, reduce overall costs and enhance the
quality of life for patients. Starting with the world's first
gastrocamera in 1950, Olympus' Endoscopic Solutions portfolio has
grown to include endoscopes, laparoscopes, and video imaging
systems, digital and integrated customer solutions, as well as
solutions for infection prevention. For more information, visit
www.olympus-global.com and follow our global Twitter account:
@Olympus_Corp.
Media contact:
Nao Tsukamoto
Global-Public_Relations@olympus.com
Olympus Corp [TYO: 7733] [ADR: OCPNY] [GDR: OLYS]
https://www.olympus-global.com
Copyright 2022 JCN Newswire . All rights reserved.